LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

NTRK Fusion-Positive Congenital Spinal Glioblastoma treated with Carboplatin, Etoposide, and Larotrectinib

Photo by nate_dumlao from unsplash

Introduction Primary spinal glioblastoma multiforme (GBM) is a rare central nervous system tumor accounting for less than 3% of pediatric central nervous system tumors. The congenital form of this malignancy… Click to show full abstract

Introduction Primary spinal glioblastoma multiforme (GBM) is a rare central nervous system tumor accounting for less than 3% of pediatric central nervous system tumors. The congenital form of this malignancy is even more unusual. Here we present a case of a newborn diagnosed at birth with an advanced spinal cord congenital glioblastoma and successfully treated with etoposide/carboplatin chemotherapy and Larotrectinib. Case Description The patient was born full term via induced vaginal delivery due to decreased fetal movement. She was noted to have decreased tone in the delivery room, with a postured right arm; MRI of the brain and spine revealed an infiltrative mass in …

Keywords: fusion positive; glioblastoma; spinal glioblastoma; ntrk fusion; larotrectinib; positive congenital

Journal Title: Pediatrics
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.